Cel-Sci Corporation (CVM)

Business: CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases.

IPO Date: 01-Jan-1987

Chief Exec. & Financial Officer, Treasurer and Director: Mr. Geert R. Kersten Esq.

Sr. VP of Operations & Corp. Sec.: Ms. Patricia B. Prichep

Listing: NYSE: CVM

Country: United States

Headquarters: Vienna, VA

Website: https://cel-sci.com

Market cap: $182.41 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-36.01 Mln

Cash: $34.28 Mln

Total Debt: $16.05 Mln

Insider's Holding: 3.90%

Liquidity: Low

52 Week range: $2.50 - 12.90

Shares outstanding: 43,328,100

10 Years Aggregate:

• CFO: $-142.36 Mln
• EBITDA: $-241.66 Mln
• Net Profit: $-233.11 Mln